Monoallelic deletion of TRAIL-R1/2 (TNFRSF10A/B, also called death receptor 4/5 (DR4/DR5)) can antagonize TRAIL-induced apoptosis in B-NHL18, suggesting that TRAIL-R1/2 may function as tumour suppressors. Here, TNFSF10 is linked to neoplasm.